Pilot Clinical Study of an Endoscopic, Removable Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes

Obese T2DM subjects were randomized to receive a DJBL (n ¼ 12) or sham endoscopy (n ¼ 6) in a 24-week study, extended up to 52 weeks.